Provide professional treatment informations for patients with liver cirrhosis.
»Home | »Sitemap | »Contact us | »Link
HomePreventing Death from Septic Shock in Patients with Cirrhosis

Preventing Death from Septic Shock in Patients with Cirrhosis

Septic shock is a major cause of admission to intensive care units among patients with cirrhosis, which results in significant morbidity, mortality, and cost. Early administration of appropriate antimicrobials and combination regimens are suggested as practice-related factors that might improve survival in this group. To investigate this issue, researchers identified 635 adult patients with septic shock and cirrhosis in a database from 28 medical centers in the U.S., Canada, and Saudi Arabia and examined relationships between factors related to delivery of antimicrobial therapy and hospital mortality.

The mean age of the cohort was 56 years, and the mean model for end-stage liver disease score was 26.7. Hospital mortality was 75.6%. Inappropriate initial antimicrobial therapy was administered in 24.4% of patients and was associated with increased risk for mortality (adjusted odds ratio, 9.5; 95% confidence interval, 4.3–20.7). A delay in administration of appropriate antimicrobial therapy was also associated with an increased risk for mortality (adjusted OR for each hour of delay, 1.1; 95% CI, 1.1–1.2). Finally, 72.9% of patients with bacterial septic shock received only a single antibiotic agent, which was associated with an increased risk for mortality compared with receipt of 2 agents (adjusted OR, 1.8; 95% CI 1.0–3.3).

Related articles

YHK effective: Fatty Liver(NASH)

YHK:Inhibitory effect for the liver cancerous

YHK effective: the treatment of Hepatitis C

Anti-fibrotic(liver) effect of YHK

What's YHK

About Liver Cirrhosis

Eight Causes of Liver Cirrhosis

Antifibrotic treatment is the last line of defense to prevent liver cirrhosis.

Treatment of Liver Cirrhosis

  • Liver dysfunction
  • liver cirrhosis, NASH, fatty liver, hepatitis
  • Patients with liver diseases troubled by the side effects of drugs
I was infected with hepatitis C and then it developed to liver cirrhosis.I started to take YHK in 2006, after one week, my ALT and AST values began to decrease. In Dec, I stopped the injection treatment.YHK help me a lot..
I’m a liver cirrhosis patient. I was hospitalized three times within three years and the doctor told me that the prognosis was bad.Then my friend strongly recommended me to take YHK. After taking YHK, my liver function turned better, and the jaundice disappeared as well.
and more.... »
Copyright ⓒ 2012 All Rights Reserved